Hospital Mater Dei SA
Hospital Mater Dei SA operates in the healthcare sector, providing medical services and facilities, and generates revenue primarily through patient care and related healthcare services.
Business. Hospital Mater Dei SA (MATD3.SA) is a healthcare facilities and services company headquartered in Brazil. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the B3 (São Paulo) stock exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Hospital Mater Dei SA (MATD3.SA) is a healthcare facilities and services company headquartered in Brazil. The firm operates within the Healthcare Services & Equipment sector, providing medical services on a service-revenue basis. It is primarily listed on the B3 (São Paulo) stock exchange. Specific details regarding operating segments and geographic revenue mix are not disclosed.
Hospital Mater Dei SA has a market price of 5.12 BRL and a market cap of 1,699,314,816 BRL, with a price-to-book ratio of 1.09 and a price-to-tangible-book ratio of 1.09. The company's enterprise value to EBITDA is -5.44, indicating a negative EBITDA, and an enterprise value to revenue of 6.07. The company's return on equity is -0.2991, and return on assets is -0.0942, both significantly below industry norms.
The company's profitability is underperforming relative to industry standards, with a negative operating income of -652,319,000 BRL and a net income of -464,267,000 BRL. The debt-to-equity ratio is 1.36, and the current ratio is 2.49, suggesting moderate liquidity but a high level of leverage. The company's free cash flow is -485,723,000 BRL, indicating a significant outflow of cash.
Hospital Mater Dei SA's revenue is concentrated in a single segment, with no disclosed geographic diversification. The company's capital expenditure of -131,064,000 BRL reflects ongoing investment in infrastructure and facilities. The company's operating cash flow of 45,656,000 BRL is positive but insufficient to cover the free cash flow outflow.
The company's growth trajectory is uncertain, with a negative operating income and net income. The company's revenue of 585,343,000 BRL is a key metric to monitor for future performance. Analysts have provided a mean price target of 6.76 BRL and a median price target of 7.00 BRL, with a mean recommendation of 2.50, indicating a mixed outlook.
The company faces moderate liquidity risk, with a negative net cash position after subtracting total debt. The risk of dilution is low, and the company has not issued additional shares recently. The company's financial structure and performance suggest a need for careful monitoring of liquidity and profitability.
Recent events and filings indicate that the company is under pressure to improve its financial performance. The company's operating cash flow is positive, but the free cash flow is negative, indicating a need for cost management and revenue growth. The company's capital expenditure is a significant outflow, and the company's debt levels are high.
- Hospital Mater Dei SA is operating at a loss, with a negative operating income and net income.
- The company's liquidity is moderate, with a current ratio of 2.49 but a negative net cash position.
- The company's debt-to-equity ratio is 1.36, indicating a high level of leverage.
- Analysts have a mixed outlook, with a mean price target of 6.76 BRL and a median price target of 7.00 BRL.
- The company's free cash flow is negative, indicating a need for cost management and revenue growth.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Revenue BRL 575.0M, +15,2% YoY; Operating income +37,7% YoY.
- ▍Revenue BRL 575.0M, +15,2% YoY
- ▍Operating income +37,7% YoY
- ▍Net income +66,6% YoY
- ▍Free cash flow +44,6% YoY
- ▍Net margin 5.8%
Revenue BRL 562.3M; Operating income BRL 98.3M.
- ▍Revenue BRL 562.3M
- ▍Operating income BRL 98.3M
- ▍Net margin 6.7%
Revenue BRL 567.9M; Operating income BRL 98.1M.
- ▍Revenue BRL 567.9M
- ▍Operating income BRL 98.1M
- ▍Net margin 4.7%
Revenue BRL 545.8M, −6,8% YoY; Operating income +113,5% YoY.
- ▍Revenue BRL 545.8M, −6,8% YoY
- ▍Operating income +113,5% YoY
- ▍Net income +105,7% YoY
- ▍Free cash flow +109,8% YoY
- ▍Net margin 4.8%
Revenue BRL 499.3M; Operating income BRL 69.3M.
- ▍Revenue BRL 499.3M
- ▍Operating income BRL 69.3M
- ▍Net margin 4.0%
Revenue BRL 585.3M; Operating income -BRL 652.3M.
- ▍Revenue BRL 585.3M
- ▍Operating income -BRL 652.3M
- ▍Net margin -79.3%
Revenue BRL 2.18B; Operating income BRL 353.7M.
- ▍Revenue BRL 2.18B
- ▍Operating income BRL 353.7M
- ▍Net margin 5.1%
Revenue BRL 1.76B, +72,1% YoY; Operating income +39,5% YoY.
- ▍Revenue BRL 1.76B, +72,1% YoY
- ▍Operating income +39,5% YoY
- ▍Net income −28,6% YoY
- ▍Free cash flow −267,8% YoY
- ▍Net margin 5.9%
Revenue BRL 1.02B; Operating income BRL 242.3M.
- ▍Revenue BRL 1.02B
- ▍Operating income BRL 242.3M
- ▍Net margin 14.1%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,52 |
| Revenue | —no estimate | —no estimate | 2,4B BRL |
| Operating income | —no estimate | —no estimate | 424,7M BRL |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Hospital Mater Dei SA Market data — financials · 2026-05-28
- Hospital Mater Dei SA Market data — analyst estimates · 2026-05-28